Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity

Part of paid clinical trials in Meridian, Idaho.

Sponsor
Novo Nordisk A/S
Study ID
NCT02918279
Phase
PHASE3
Status
Completed

Conditions

  • Metabolism and Nutrition Disorder
  • Obesity

Eligibility Criteria

Sex
ALL
Age
12 Years - 17 Years
Healthy Volunteers
Not accepted

Interventions

  • Liraglutide — DRUG
    Administered once daily subcutaneously (s.c., under the skin)
  • Placebo — DRUG
    Administered once daily subcutaneously (s.c., under the skin)

Study Details

This trial is conducted globally. The aim of this trial is to investigate the effect of liraglutide for weight management in pubertal adolescent subjects with obesity.

Key Dates

Start date
Sep 29, 2016
Status verified
Apr 2020
Primary completion
Feb 14, 2019
Completion
Aug 8, 2019

Study Design

Enrollment
251 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Liraglutide
  • Placebo Comparator: Placebo

Primary Outcome Measure

Change in BMI SDS (Week 0, Week 56) [ Time Frame: Week 0, week 56 ]

Locations (13)

FacilityCityStateZIPSite coordinators
Novo Nordisk Investigational SiteMeridianIdaho83646-
Novo Nordisk Investigational SiteBaton RougeLouisiana70808-4124-
Novo Nordisk Investigational SiteBaltimoreMaryland21229-
Novo Nordisk Investigational SiteMinneapolisMinnesota55455-
Novo Nordisk Investigational SiteBuffaloNew York14222-
Novo Nordisk Investigational SiteColumbusOhio43213-
Novo Nordisk Investigational SiteDaytonOhio45406-
Novo Nordisk Investigational SiteDaytonOhio45419-
Novo Nordisk Investigational SitePittsburghPennsylvania15224-
Novo Nordisk Investigational SiteCharlestonSouth Carolina29425-
Novo Nordisk Investigational SiteGoose CreekSouth Carolina29445-
Novo Nordisk Investigational SiteGreenvilleSouth Carolina29615-
Novo Nordisk Investigational SiteMemphisTennessee38119-

Find similar trials in Meridian, ID

By condition
Obesity / overweight
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
Novo Nordisk Investigational Site· Meridian, IDNovo Nordisk Investigational Site· Baton Rouge, LANovo Nordisk Investigational Site· Baltimore, MDNovo Nordisk Investigational Site· Minneapolis, MNNovo Nordisk Investigational Site· Buffalo, NYNovo Nordisk Investigational Site· Columbus, OH

Related Studies